Clinical evaluation of perhexiline maleate in the treatment of patients with chronic coronary insufficiency.
D000284:Administration, Oral; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001219:Aspartate Aminotransferases / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004562:Electrocardiography; D005260:Female; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D005996:Nitroglycerin / Q000627:therapeutic use; D010101:Oxygen Consumption; D010480:Perhexiline / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D011379:Prognosis
D010880:Piperidines; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D005996:Nitroglycerin; D010480:Perhexiline